International Edition
Latest News
Health

Antidepressants in Pregnancy: Study of 167,477 Children

Antidepressants during pregnancy are linked to an increased rate of special educational needs in children, according to a study published on September 29, 2026, in the journal PLOS Medicine. Researchers at the University of Glasgow analyzed linked health…

Antidepressants in Pregnancy: Study of 167,477 Children

Antidepressants during pregnancy are linked to an increased rate of special educational needs in children, according to a study published on September 29, 2026, in the journal PLOS Medicine. Researchers at the University of Glasgow analyzed linked health and school records for 167,477 children born in Wales between 2009 and 2016 and followed through 2022, finding that medicated maternal depression is associated with a 27 percent rate of educational support needs compared to 20 percent in unexposed controls.

Analysis of 167,477 Welsh School Children Reveals Educational Support Rates

The study, led by Saraid McIlvride, evaluated how maternal depression and antidepressant exposure affect later neurodevelopment. Among children with no documented maternal depression or antidepressant exposure, approximately 20 percent required special educational support. That figure rose to roughly 24 percent for children whose mothers had unmedicated depression, and climbed to about 27 percent for those exposed to treated depression. Where antidepressants were prescribed without a documented maternal depression diagnosis, the rate stood at roughly 26 percent.

Mathematically, antidepressant exposure was linked to 6.3 additional cases per 100 children among those without maternal depression, and 2.9 additional cases per 100 children among those with maternal depression. The research team notes that this observed association could be explained by a more severe depressive illness in the medicated women.

Depression and Antidepressants in Pregnancy: What a Large Welsh Study Found About Children's Le

Both maternal depression and antidepressant use showed statistical links in the records to attention deficit hyperactivity disorder, autism, and various emotional and behavioral difficulties. However, when researchers directly compared children of treated mothers against those of untreated mothers with depression, no clear difference emerged regarding autism and ADHD diagnoses.

Several methodological limitations qualify these findings. The dataset lacked specific metrics regarding the exact severity of maternal depression. Investigators also did not track whether mothers actually consumed the prescribed medications or whether they consumed alcohol or drugs, as these factors were absent from the underlying records.

Given the complex trade-offs between managing maternal mental health and protecting fetal development, the study authors advise against stopping antidepressant medication automatically or prematurely. Because untreated depression can pose significant risks to both mother and child, investigators recommend that treatment decisions occur on an individual basis through direct consultations with attending physicians.

Frequently Asked Questions About Antidepressant Use During Pregnancy

What specific neurodevelopmental outcomes did the study examine in children?

The University of Glasgow research evaluated special educational needs within the school environment alongside specific diagnoses such as ADHD, autism, and emotional or behavioral difficulties among children born between 2009 and 2016.

Why did children whose mothers took antidepressants show higher rates of support needs?

Study authors emphasize that the observed link could be explained by the greater severity of depressive illness in women who received medical treatment compared to those who did not take medications.

What major data limitations did the research group identify?

The underlying health and educational records for the 167,477 children did not document the precise severity of maternal depression, whether patients actually ingested their prescribed medications, or any potential maternal use of alcohol and drugs.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”